Alpha memo: resveratrol exercise training cross-context evidence signal

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

Minor issues

• The Receipt 2 excerpt appears truncated at 'Exercise training led to a 45' (likely 45% increase in MAP or similar) — minor cosmetic issue, not affecting boundedness.
• The memo could briefly note that Receipt 1 measures a different endpoint family (intestinal inflammation/ferroptosis) versus Receipt 2 (cardiovascular health), reinforcing the cross-context framing.

Reviewer note

Bounded, source-grounded alpha memo. The title and one-sentence alpha are precisely anchored to the two cited receipts: a 2023 mouse study (15 mg/kg/day resveratrol + 28-day swimming) showing attenuation of high-intensity training–induced intestinal inflammation/ferroptosis via Nrf2/FTH1/GPX4, and a 2013 human RCT (n=27 aged men, 250 mg/day trans-resveratrol + 8 weeks high-intensity training) showing resveratrol blunts training-induced cardiovascular gains. The cross-context signal (mouse intestinal protection vs. human cardiovascular interference) is well-defined, falsifiable, and proportionate. Caveats correctly flag species, dose, duration, and endpoint differences, and the memo explicitly declines to issue clinical, dosing, or supplementation recommendations. Falsifiers are concrete and actionable. Source bundle entries match the in-text citations exactly. Hedging language ('may attenuate,' 'suggests interference,' 'heterogeneous cross-context signal') is appropriate scholarly calibration, not overclaim. Synthesis is adequate rather than strong because the memo is deliberately minimal, but the integration of the two receipts into a coherent surprising-signal narrative is clear and well-bounded. No major issues detected.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: consensus

Prompt: reviewer-v11-research-synthesis